Wenkuan Chen
Overview
Explore the profile of Wenkuan Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie J, Lin X, Deng X, Tang H, Zou Y, Chen W, et al.
Cancer Drug Resist
. 2025 Feb;
8:2.
PMID: 39935427
Cancer-associated fibroblasts (CAFs) constitute a critical component of the tumor microenvironment (TME). CAFs can be reprogrammed by cancer cells, leading to the production of extracellular vesicles (EVs). These EVs serve...
2.
Xie J, Deng X, Yang A, Zheng S, Tang Y, Xie Y, et al.
Int J Surg
. 2025 Feb;
PMID: 39907625
No abstract available.
3.
Tang Y, Cai Q, Tian Z, Chen W, Tang H
Research (Wash D C)
. 2025 Jan;
8():0600.
PMID: 39850365
Gut microbiota is crucial for protecting the homeostasis of immune locally and systemically, and its dysbiosis is essentially correlated to tumorigenesis, cancer progression, and refractoriness to cancer treatments, including the...
4.
Wang Y, Cheng S, Fleishman J, Chen J, Tang H, Chen Z, et al.
Drug Resist Updat
. 2024 Jun;
75:101099.
PMID: 38850692
Anoikis, known as matrix detachment-induced apoptosis or detachment-induced cell death, is crucial for tissue development and homeostasis. Cancer cells develop means to evade anoikis, e.g. anoikis resistance, thereby allowing for...
5.
Chen X, Wu Z, Wang J, Teng Q, Tang H, Liu Q, et al.
Front Pharmacol
. 2024 May;
15:1400699.
PMID: 38756373
The therapeutic effect of chemotherapy and targeted therapy are known to be limited by drug resistance. Substantial evidence has shown that ATP-binding cassette (ABC) transporters P-gp and BCRP are significant...
6.
Yan S, Liu L, Zhang X, Wei L, Jiang W, Gao X, et al.
Clin Transl Oncol
. 2023 Nov;
26(5):1192-1202.
PMID: 37989823
Background: The study aimed to investigate the efficacy and survival outcomes of neoadjuvant chemotherapy combined with programmed cell death protein 1 (PD-1) blockade (neoadjuvant chemoimmunotherapy) for patients with resectable head...
7.
Li L, Chen L, Li Z, Huang S, Chen Y, Li Z, et al.
BMC Oral Health
. 2023 Jul;
23(1):519.
PMID: 37491232
Background: Oral squamous cell carcinoma (OSCC) is a disease with increasing incidence worldwide that leads to deformity and death. In OSCC, fascin actin-bundling protein 1 (FSCN1) is an oncogene involved...
8.
Jiang W, Li Y, Li R, Chen W, Song M, Zhang Q, et al.
J Pers Med
. 2023 Mar;
13(3).
PMID: 36983712
It has been reported that forkhead box D1 (FOXD1) plays an established role in human early embryonic development and is broadly involved in various malignancies. However, there is limited information...
9.
Analysis of T1-T2 stage oropharyngeal squamous cell carcinoma treated with transoral robotic surgery
Li H, Zhang X, Chen W, Zhang Q, Li Q, Chen S, et al.
Laryngoscope Investig Otolaryngol
. 2023 Feb;
8(1):103-112.
PMID: 36846425
Objective: Transoral robotic surgery (TORS) has become an effective treatment for early-stage oropharyngeal squamous cell carcinomas (OPSCCs). We aimed to analyze the clinical safety and efficacy of TORS for human...
10.
Tan Q, Yang Q, Li H, Li M, Chen W, Liang Z, et al.
Ann Otol Rhinol Laryngol
. 2022 Aug;
132(8):905-911.
PMID: 36039471
Objectives: Nasopharyngeal adenocarcinomas (NPACs) are rare malignant tumors. The treatment of NPACs is usually surgery with resection of normal nasal passage tissues.We introduced an innovative double endoscopic surgery for NPACs...